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Abstract
The co-catabolism of multiple host-derived carbon substrates is
required by Mycobacterium tuberculosis (Mtb) to successfully
sustain a tuberculosis infection. However, the metabolic plasticity
of this pathogen and the complexity of the metabolic networks
present a major obstacle in identifying those nodes most amenable
to therapeutic interventions. It is therefore critical that we define
the metabolic phenotypes of Mtb in different conditions. We
applied metabolic flux analysis using stable isotopes and lipid fin-
gerprinting to investigate the metabolic network of Mtb growing
slowly in our steady-state chemostat system. We demonstrate that
Mtb efficiently co-metabolises either cholesterol or glycerol, in
combination with two-carbon generating substrates without any
compartmentalisation of metabolism. We discovered that parti-
tioning of flux between the TCA cycle and the glyoxylate shunt
combined with a reversible methyl citrate cycle is the critical
metabolic nodes which underlie the nutritional flexibility of Mtb.
These findings provide novel insights into the metabolic architec-
ture that affords adaptability of bacteria to divergent carbon
substrates and expand our fundamental knowledge about the
methyl citrate cycle and the glyoxylate shunt.
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Introduction
Mycobacterium tuberculosis (Mtb) is the causative agent of a global
tuberculosis (TB) pandemic which has now reached staggering
levels making Mtb once again a leading cause of death globally
(World Health Organisation, 2020). The terrifying trend of increas-
ing antibiotic-resistant TB is destabilising TB control measures
making new therapeutics which target drug-resistant strains of Mtb
an urgent priority (Singh et al, 2020). Mtb is an unusual bacterial
pathogen, which has the remarkable ability to cause both acute life-
threatening disease and clinically latent infections that can persist
for the lifetime of the human host.
Mycobacterium tuberculosis spends much of its life cycle growing
intracellularly within the phagosomal compartment of macrophages
where nutrient availability will fluctuate (Warner, 2014; Huang
et al, 2018). In addition to replicating within the phagosomal
compartment, it has been shown that Mtb can escape the intracellu-
lar environment to survive extracellularly (Grosset, 2003), in other
cell types and within the diverse and dynamic microenvironments
of granulomas (Bussi & Gutierrez, 2019). Mtb must therefore be able
to survive in a plethora of different microenvironments and nutri-
ents. Experimental evidence has identified central carbon metabo-
lism as instrumental to this pathogenic strategy, and therefore, our
research is focused on investigating the metabolic capabilities of
Mtb both in vitro and ex vivo (Beste et al, 2007a; Beste et al, 2011;
Beste et al, 2013; Lofthouse et al, 2013; Basu et al, 2018; Borah
et al, 2019; Lopez-Agudelo et al, 2020).
Mycobacterium tuberculosis maintains a functional tricarboxylic
acid (TCA) cycle, pentose phosphate pathway (PPP) and Embden–
Meyerhof–Parnas (EMP) pathway, as well as enzymes providing a
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metabolic link between glycolysis and the TCA cycle (Beste &
McFadden, 2010). Mtb also has two alternative pathways (methyl
citrate cycle and the B12-dependent methylmalonyl pathway) for
metabolising propionyl-CoA derived from the metabolism of sterols,
uneven branched chain fatty acids and amino acids (Eoh & Rhee,
2014). These pathways allow Mtb to utilise a wide range of carbon
sources that includes carbohydrates, sugars, fatty acids, amino acids
and sterols (Warner, 2014). Whilst the basic architecture of central
carbon metabolism of Mtb is now well established, there are still
many questions regarding how the flux of metabolites through this
network is modulated under various different nutritional conditions.
Using stable isotope-labelled nutrients for studying the metabo-
lism of Mtb has proved extremely informative (de Carvalho et al,
2010; Marrero et al, 2010; Beste et al, 2011; Beste et al, 2013; Eoh &
Rhee, 2014; Nandakumar et al, 2014; Basu et al, 2018; Borah et al,
2019). Metabolic labelling experiments using 13C-labelled combina-
tions of acetate, glycerol and glucose have demonstrated that Mtb is
able to co-catabolise two carbon sources simultaneously demon-
strating that Mtb does not use carbon catabolite repression to regu-
late metabolism (de Carvalho et al, 2010). This work also suggested
that Mtb not only co-catabolised these carbon substrates but did so
in a compartmentalised and segregated manner. However, impor-
tantly this work was not able to determine the metabolic flux pro-
files on these combinations of carbon substrates. Understanding
metabolic fluxes of Mtb during co-catabolism of multiple carbon
sources will allow us to identify nodes of metabolism most amen-
able to therapeutic intervention. By combining isotopomer labelling
with our steady-state chemostat model system of mycobacterial
growth allowed us to perform 13C-metabolic flux analysis (MFA) at
different growth rates in carbon limited conditions (Beste et al,
2011). Previously, we identified the activity of a novel GAS pathway
for pyruvate dissimulation when Mtb was growing slowly on glyc-
erol and oleic acid and demonstrated that the pathway requires isoc-
itrate lyase and the enzymes of the anaplerotic node (Beste et al,
2011) both of which are important for the survival of Mtb in the
host (McKinney et al, 2000; Basu et al, 2018).
Glycerol was not considered an important carbon source for Mtb
as glycerol kinase (glpK), which is an essential gene for the conver-
sion of glycerol to glycerol 3-phosphate (Beste et al, 2009), is
dispensable for the growth of Mtb in a murine TB model (Pethe
et al, 2010). However, the detection of glycerol in human-like TB
lesions has compelled a re-evaluation of the role of glycerol and
glycerol containing metabolites in the life cycle of Mtb (Safi et al,
2019). Moreover, Mtb has been shown to co-metabolise a mixture
of carbon substrates when growing in host macrophage cells that
included an unknown glycolytic C3 substrate (Beste et al, 2013) that
could potentially be glycerol.
Metabolomic and gene-deletion studies have highlighted fatty
acids and cholesterol as critical to the nutrition, survival and viru-
lence of Mtb (McKinney et al, 2000; Pandey & Sassetti, 2008) and
that Mtb encounters and co-metabolises both substrates simultane-
ously in vivo (Wilburn et al, 2018). Cholesterol, uneven chain fatty
acids and branched chain amino acids are all catabolised to provide
Mtb with the metabolite propionyl-CoA which although required for
the synthesis of important virulence cell wall lipids (phthiocerol
dimycocerosate (PDIM), polyacylated trehalose and sulpholipids) is
also toxic if allowed to accumulate intracellularly (Griffin et al,
2012; Lee et al, 2013). In addition to metabolising propionyl-CoA
through the methyl citrate cycle (MCC) or in the presence of vitamin
B12, the methylmalonyl cycle, Mtb can also sequester propionyl-
CoA into methyl branched cell wall lipids (Lee et al, 2013). During
infection, it is thought that Mtb uses fatty acids to prime this process
further suggesting that cholesterol and fatty acid metabolism occur
simultaneously in vivo (Lee et al, 2013; Wilburn et al, 2018). Despite
numerous biochemical studies to elucidate the biochemical degrada-
tion pathways and studies exploring the role of specific enzymes in
cholesterol and fatty acid metabolism, the metabolic flux profile of
Mtb growing on this combination of substrates has never been
directly measured. Therefore, in this study we performed 13C-MFA
on steady-state, slowly growing cultures of Mtb using an extended
version of our 13C isotopomer model (Beste et al, 2011), which
includes the MCC. We compared the metabolic flux profile of
chemostat cultures of Mtb growing in defined carbon limited condi-
tions growing with cholesterol/acetate with those growing on glyc-
erol/Tween 80 to reflect carbon sources available to Mtb during the
life cycle of this pathogen within the host.
We demonstrate that when Mtb is growing slowly on cholesterol
and acetate, Mtb utilises a complete TCA cycle in combination with
the glyoxylate shunt. There is very little demand for the MCC in these
conditions as lipid fingerprinting identified that the propionyl-
CoA-derived cholesterol is being preferentially incorporated into lipids.
Conversely when growing on glycerol and Tween 80, Mtb utilises an
incomplete TCA cycle and the methyl citrate cycle is reversed to
provide propionyl-CoA for the synthesis of virulence lipids. This work
highlights that re-routing fluxes through the TCA cycle, MCC and the
glyoxylate shunt and in particular the ability to alternate the direction
of the MCC, whilst co-metabolising carbon substrates during slow
growth is critical to the metabolic flexibility of Mtb.
Results
Isotopic profiling of chemostat grown Mtb
demonstrated efficient co-catabolism of carbon sources
without metabolic compartmentalisation
To define the metabolic profile of Mtb growing on cholesterol and
acetate, Mtb H37Rv cultures were grown in carbon limited chemo-
stats operating at a dilution rate of µ = 0.01 h (doubling time
(td) = 69 h). We adopted this dilution rate as we have previously
demonstrated that the transcriptional response at this growth rate
has many similarities to the transcriptional response characteristic
of the adaptation of Mtb to the macrophage environment, and
others have shown a similar profile from Mtb isolated from sputum
(Beste et al, 2007b). The cultures were grown in Roisin’s minimal
medium (Beste et al, 2005) with a combination of either choles-
terol/acetate (CHL-ACE) or glycerol/Tween 80 (GLY-OLA) as previ-
ously described (Beste et al, 2011). After approximately three
volume changes, little variation was observed in the CO2 and
biomass production rates, indicating that a metabolic steady-state
conditions had been attained (Fig EV1). Data from the chemostat
cultures demonstrated that Mtb was able to co-metabolise acetate
and cholesterol simultaneously with similar yields of bacteria to
cultures growing on glycerol and Tween 80. Substrate uptake rates
were also comparable under the two growth conditions, but the CO2
production rate was significantly higher in CHL-ACE (Table 1).
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For the labelling experiments, steady-state chemostat cultures
were switched to identical media containing 13C-labelled substrates
(30% [13C3]glycerol OR 100% [
13C2]acetate). Samples were taken
every volume change for a total of four volume changes to ensure
that an isotopic stationary state was attained. Labelling of proteino-
genic amino acids and intracellular metabolites was measured using
gas chromatography–mass spectrometry (GC-MS) or liquid chro-
matography–mass spectrometry (LC-MS) as previously described
(Beste et al, 2011). Proteinogenic amino acids are commonly
measured for 13C-MFA as they are much more abundant and stable
than their precursors and provide extensive labelling information.
Moreover, amino acids can be used to directly deduce the labelling
patterns of their precursor metabolites. The labelling pattern of the
amino acids changed very little between the third and fourth volume
change confirming that the culture had reached an isotopic steady
state which is essential for determining intracellular fluxes using
13C-MFA (Table 1; Fig EV1C and D).
Previous studies indicated that Mtb was operating a form of
compartmentalised metabolism when growing on solid 7H10 agar
containing combinations of the carbon sources glucose, glycerol and
acetate whereby individual substrates had distinct metabolic fates
(de Carvalho et al, 2010). However, our 13C labelling data from
chemostat cultures at metabolic and isotopic steady state showed no
evidence of such compartmentalisation when Mtb was grown with
either GLY-OLA or CHL-ACE as evidenced by uniform distribution
of both unlabelled and 13C-labelled substrates (Fig 1).
For steady-state CHL-ACE Mtb cultures, the 13C labelling pro-
files reflect the entry points of cholesterol into central carbon
metabolism. Cholesterol catabolism yields four propionyl-CoA, four
acetyl-CoA, one pyruvate and one succinyl-CoA of which succinyl-
CoA, pyruvate and acetyl-CoA enter central carbon metabolism
directly (Crowe et al, 2017). Propionyl-CoA is toxic to Mtb and
can be metabolised by either: (i) the methyl citrate cycle to pyru-
vate, (ii) the B12-dependent methylmalonyl pathway leading to
succinyl-CoA, or (iii) used in cell wall lipogenesis. In our experi-
ments, the methylmalonyl pathway is not active (as Roisin’s media
lacks vitamin B12).
For the CHL-ACE experiments, the labelling profile of succinate
(SUC), pyruvate (PYR) and the pyruvate-derived amino acids
(alanine (ALA), valine (VAL) and leucine (LEU)) had ≥ 50% unla-
belled carbon indicating that the carbon backbone of these metabo-
lites was predominantly derived from unlabelled cholesterol. This is
expected as cholesterol enters central carbon metabolism as succi-
nate and pyruvate. Canonical 13C labelling patterns were measured
in the other metabolites reflecting that 60% of the total carbon was
derived from 13C-labelled acetate and the remainder derived from
unlabelled cholesterol indicating that metabolism was also not
compartmentalised in these conditions (Fig 1). For GLY-OLA grown
cultures, the labelling profiles were consistent across the different
metabolites analysed; the backbone of these metabolites was
synthesised primarily from glycerol, demonstrating that metabolism
of GLY-OLA was also not compartmentalised.
13C isotopologue analysis of amino acids defines their
biosynthetic routes
We performed 13C isotopologue analysis of proteinogenic amino
acids. As expected, the profiles of all metabolites derived from CHL-
ACE were different to that derived from GLY-OLA grown Mtb
(Fig 2). The labelling profiles of amino acids reflect their biosyn-
thetic origin for both GLY-OLA and CHL-ACE grown Mtb. For the
GLY-OLA cultures, the labelling patterns of aspartate (ASP/N), thre-
onine (THR), isoleucine (ILE), lysine (LYS) and methionine (MET)
were similar, consistent with a common biosynthetic origin of these
amino acids from oxaloacetate. The isotopologue composition of
tyrosine (TYR) and phenylalanine (PHE) was also alike reflecting
their common precursors – phosphoenolpyruvate and erythrose-
4-phosphate. Similarly, ornithine (ORN) and glutamate (GLU/N),
which are both derived from a-ketoglutarate, had similar labelling
patterns. The isotopologue profiles of proteinogenic amino acids
derived from steady-state cultures grown in CHL-ACE also reflect
their biosynthetic origin. THR and MET had near identical profiles
with ASP/N with M + 2 and M + 4 isotopomers having the highest
13C labelling, indicating their synthesis from ASP. GLU/N and ORN,
TYR and PHE and ALA and SER all had very similar profiles indicat-
ing the common biosynthetic precursor for each of these pairs of
amino acids. Whilst manual analysis of 13C isotopologue data allows
qualitative conclusions, systems level analysis is required in order
to quantitate the metabolic fluxes.
Improved 13C-Metabolic Flux Analysis using an expanded
isotopomer model
13C-MFA is the preferred tool for quantitative characterisation of
metabolic phenotypes in steady-state cultures (Wiechert, 2001).
Previously, we developed an isotopomer model of Mtb’s central
carbon metabolism comprising of the TCA cycle, glycolysis, pentose
phosphate pathway (PPP) and anaplerotic reactions, which allowed
us to analyse 13C-isotopomer data and compute metabolic fluxes
(Beste et al, 2011). For this study, we have expanded our capacity
for predicting metabolic fluxes by adding the methyl citrate cycle
(MCC) and amino acid degradation pathways to our previous 13C-
isotopomer model (Table EV1). Absolute flux distributions were
derived from the two steady-state chemostat conditions (Fig 3)
using the INCA platform (Young, 2014). In our previous study, we
were unable to determine the flux values unambiguously for Mtb
growing in GLY-OLA. Here by using our extended isotopomer
Table 1. Steady-state characteristics of Mycobacterium tuberculosis
grown in carbon limited chemostats.
Carbon sources CHL-ACE GLY-OLA
Dilution rate (h1) 0.01 0.01
Biomass (g dry weight l1) 0.49 2.18
CFU (× 107 ml1) 3.9 33






Acetate = 0.26 Glycerol = 0.23
Cholesterol = 0.0085 Oleic acid = 0.002
CO2 production rate (mmol
g biomass1 h1)
0.245 0.178
Yield (g biomass1 mmol
carbon1)
0.013 0.012
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model, we obtained a unique metabolic flux profile for these condi-
tions building on our previous work (Fig 3). A comparison of the
current and the previous metabolic flux profiles of Mtb growing
in GLY-OLA in steady-state cultures (Fig EV2) illustrates the
similarities between the solutions and shows that extending the
isotopomer model has improved our ability to resolve the metabolic
fluxes of Mtb.
Distinct metabolic flux partitioning between the TCA cycle and
glyoxylate shunt during co-catabolism
The resolved flux distributions of Mtb growing on CHL-ACE demon-
strated that there is a significant difference between how Mtb
partitions carbon flux between the TCA cycle and the glyoxylate
shunt in CHL-ACE as compared with GLY-OLA (Fig 3A). When
growing on CHL-ACE, Mtb operates a complete oxidative TCA cycle
in combination with an active glyoxylate shunt. There is only a very
low flux through pyruvate dehydrogenase (PDH) (TCA R1) with the
small amount of cholesterol-derived pyruvate being channelled to
leucine, valine and alanine biosynthesis (Figs 3A, and 4A and B). In
concordance with our previous work, Mtb uses an incomplete TCA
cycle when growing on GLY-OLA (Beste et al, 2011).
Determining the individual anaplerotic fluxes from 13C-
isotopomer data presents a major challenge. For example, it is not
possible to discriminate between the reactions of malic enzyme
(MEZ) and pyruvate carboxylase (PCA) with high confidence so the
Figure 1. 13C incorporation into the proteinogenic amino acids and intracellular metabolites from metabolic and isotopic steady-state chemostat
Mtb cultures.
Label distribution is shown in metabolites from Mtb grown in 30% [13C3] glycerol and unlabelled Tween 80 which provides Mtb with oleic acid (GLY-OLA) and 100%
[13C2] acetate and unlabelled cholesterol (CHL-ACE). Average
13C incorporation was calculated for metabolites harvested at a steady-state growth and are shown as the
amount labelled (13C) and unlabelled (12C) using 3–4 independent measurements. Data are average of 3 replicate measurements. DHAP (dihydroxyacetone phosphate),
PYR (pyruvate) ALA (alanine), GLY (glycine), SER (serine), LYS (lysine), MET (methionine), ASP/N (aspartate/asparagine), THR (threonine), ILE (isoleucine), ORN (ornithine),
GLU/N (glutamate/glutamine), SUC (succinate), LEU (leucine), ILE (isoleucine), VAL (valine), PHE (phenylalanine), TYR (tyrosine), HIS (histidine), S7P (sedoheptulose-
7-phosphate), measured for CHL-ACE and R5P (ribose 5-phosphate) and measured for GLY-OLA cultures, are plotted on a metabolic map showing reactions for glycolysis,
PPP, GLX (glyoxylate shunt) and the TCA cycle. Aspartate/asparagine and glutamate/glutamine pools are lumped as both asparagine and glutamine were reduced to
aspartate and glutamate, respectively, during acid hydrolysis.
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summed flux is shown between pyruvate and malate/oxaloacetate
(ANA R2, Fig 4A and B). From the data, we identified that Mtb uses
phosphoenolpyruvate carboxykinase (PEPCK or ANA R1) gluco-
neogenically during growth on CHL-ACE to generate PEP, which is
in accordance with the use of the glyoxylate shunt for replenishing
the TCA intermediates, whereas, when growing on GLY-OLA,
PEPCK operates in the carboxylating direction to fix CO2 as we have
described previously (Beste et al, 2011). The overall flux through
ANA R2 is very low and not significantly different when growing on
CHL-ACE or GLY-OLA.
Perhaps, surprisingly, there was no flux from pyruvate to PEP,
the reaction catalysed by the fourth member of the anaplerotic node,
pyruvate phosphate dikinase (PPDK), in either condition. There was
flux towards pyruvate mediated by pyruvate kinase (PYK = EMP
R6) and this was higher on GLY/OAA than with CHL/ACE (Fig 4C
and D). We previously demonstrated using mutagenesis that
Rv1127c (annotated as PPDK) was essential for the growth of Mtb
in rich media containing cholesterol even in the presence of an
additional growth permissive carbon source (including acetate)
(Basu et al, 2018). This phenotype was associated with the inability
of the knockout Mtb strain to metabolise the cholesterol by-product
propionate, which is toxic to bacterial cells. High-throughput Tn
screen also identified Rv1127c as required for growth on cholesterol
(Griffin et al, 2011). However, other studies suggest that Mtb lacks
PPDK activity (Rhee et al, 2011). In order to explore this further, we
performed a 13C labelling experiment growing Mtb in vitro on
Roisin’s minimal medium containing [3, 4-13C2] cholesterol as a sole
carbon source (Fig 4E) This experiment identified [13C2] pyruvate,
as expected when cholesterol is catabolised; however, all of the PEP
detected was only labelled in one carbon (M + 1), indicating that
the other 13C label has been lost as CO2 via the TCA cycle consistent
with the metabolic flux prediction that Mtb lacks PPDK activity
(Fig 4D and E).
We observed only a very low gluconeogenic flux (Fig 4C and D)
during growth on CHL-ACE, which was in sharp contrast to the
glycolytic fluxes from glycerol to pyruvate, when grown on
Figure 2. 13C isotopologue analysis of proteinogenic amino acids from Mtb grown on CHL-ACE and GLY-OLA.
Measurements were obtained from Mtb grown under steady-state chemostat conditions. 13C incorporation is shown for the mass isotopomers, which are labelled as
13C1,
13C2, etc. Measurements are shown for alanine (ALA), leucine (LEU), valine (VAL), glycine (GLY), serine (SER), methionine (MET), histidine (HIS), aspartate–asparagine
(ASP/N), threonine (THR), lysine (LYS), isoleucine (ILE), glutamate–glutamine (GLU/N), ornithine (ORN), tyrosine (TYR) and phenylalanine (PHE). Glycolysis, pentose
phosphate pathway (PPP), glyoxylate shunt (GLX) and the TCA cycle are depicted. Values are shown as mean  error bars (s.d) of 3–4 replicates.
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GLY-OLA. Pyruvate kinase (PYK) was however active under both
conditions, where it funnels the PEP generated from PEPCK to pyru-
vate when growing on CHL-ACE (Fig 4C and D). On GLY-OLA, the
flux through PYK was higher, a prediction which agrees with reports
that this enzyme is required for carbon co-metabolism (Noy et al,
2016). Fluxes through the pentose phosphate pathway (PPP) were
much lower when Mtb was grown with CHL-ACE as compared to
GLY-OLA. The PPP not only supplies pentose phosphates, but also
reducing power in the form of NADPH which can then be used for
lipid biosynthesis and other anabolic processes. This may reflect a
higher demand for NADPH from the PPP when growing Mtb is
growing on GLY-OLA as compared to cultures containing the highly
reduced carbon source, cholesterol (Fig 4C and D).
Methyl citrate cycle fluxes are reversed during co-metabolism of
glycerol-oleic acid
The MCC in mycobacteria is required for the utilisation of the propi-
onyl-CoA derived from sterols, branched chain amino and fatty
acids that are acquired from the host (Fig 5A). Here, we show that
when Mtb is growing on cholesterol and acetate, there is very low
flux through the MCC suggesting that this pathway is minimally
required for cholesterol metabolism in the presence of acetate
(Fig 5A and B). Previous studies have demonstrated that the neces-
sity for the MCC can be overridden by supplying Mtb with AcCoA
generating carbon sources which primes the conversion of propi-
onyl-CoA into methylmalonyl-CoA-lipids such as sulpholipid-1
(SL-1), polyacyltrehalose (PAT) and phthiocerol dimycocerosate
(PDIM) (Lee et al, 2013). This lipid synthesis may account for the
increased biomass observed in CHL/ACE grown cells (Table 1). By
contrast when Mtb is growing on GLY-OLA, there is a reversal of
flux through the MCC (MCC R1-R3) presumably to generate propi-
onyl-CoA for lipid biosynthesis, which is also supplemented by the
degradation of the branched chain amino acid valine (D R1 and D
R2) (Fig 5B–D).
In order to explore the incorporation of carbon into lipids, we
performed MALDI-TOF analysis on Mtb from our steady-state
chemostat cultures (Fig 6A–D). These data cannot be incorporated
into flux analysis as there is no one-to-one mapping between carbon
atoms in lipids and precursor metabolites. We identified a large
number of complex lipid species, including phosphatidylinositol
mannosides (PIMs) and SL-1 (Fig 6A–D) In order to test whether
this was due to incorporation of 13C acetate into SL-1 or an
increased chain length due to the incorporation of carbon from unla-
belled cholesterol, as predicted by our flux profiles, we also
measured the lipid fingerprint of control samples derived from the
same chemostat cultures but prior to attaining an isotopic steady
state. In accordance with our metabolic flux predictions, we identi-
fied an increase in chain length in SL-1 in these unlabelled control
samples which confirmed our expectations that lipids derived from
CHL-ACE-grown Mtb had significant differences in the composition
of the methylmalonyl-CoA-derived SL-1s, specifically an increase in
chain length and abundance when compared to GLY-OLA grown
Mtb (Fig 6A and B). This is concordance with other studies which
show an increased chain length of SL-1 during growth of Mtb on
cholesterol and propionate (Griffin et al, 2012). We also found
significant mass shifts in triacylphosphatidylinositol dimannosides
(AcPIMs) isolated from the chemostat samples. However, these
shifts were not observed in the control samples indicating that in
this case, the increased mass was due to 13C-labelled acetate or glyc-
erol being incorporated into these lipids (Fig 6C and D). For CHL-
ACE-grown Mtb, the observed increased mass shift (Fig EV3A and
B) was likely due to incorporation of [13C2] acetate directly into
these lipids in contrast to the GLY-OLA chemostat grown Mtb where
unlabelled OLA was being predominantly used for acetylation
(Fig EV3).
Mtb utilises carbon and hydrogen from cholesterol to synthesise
amino acids
Since the synthesis of amino acids is required for biomass produc-
tion, we also calculated the amino acid production rates. 13C-MFA
demonstrated that there were significant differences in the amino
acid biosynthesis fluxes between the two chemostat conditions.
For example, the synthesis of ASP/ASN, GLU/GLN and ILE was
significantly higher for Mtb growing slowly with CHL-ACE than
when the carbon sources were GLY-OLA (Fig 7A). Scrutinising
these data further shows that the fluxes through GLU/GLN synthe-
sis ultimately contribute towards asparagine biosynthesis. This is
in concordance with the data showing that asparagine accumulates
during metabolism of the cholesterol by-product propionate (Lee
et al, 2018).
The increase in biosynthesis of ILE during growth on CHL-ACE is
of interest as in other fungi and bacteria it has been shown that
branched chain amino acid biosynthesis can also function as a
mechanism to dissipate reductants (Shimizu et al, 2010; Zhang et al,
2018). Supported by the lipid profiling data here, it is thought that
Mtb primarily uses lipids as an electron sink to maintain redox
homeostasis when growing on highly reduced carbon sources such
as cholesterol (Singh et al, 2009; Mavi et al, 2019). However, the
role of amino acids as potential electron sinks has never been
explored for Mtb. Thus, we grew Mtb in Roisin’s minimal medium
containing uniformly deuterated cholesterol and measured the
incorporation of deuterium into amino acids. This analysis showed
that Mtb incorporates hydrogen from cholesterol into several amino
acids with branched chain amino acids having the highest level of
incorporation (Fig 7B). These data suggest that amino acid anabo-
lism could provide Mtb with another mechanism for sinking elec-
trons and maintaining redox homeostasis when consuming highly
reduced carbon sources such as cholesterol. Interpretation of 2H
◀ Figure 3. Flux distributions of Mtb grown on CHL-ACE (A) and GLY-OLA (B) carbon substrate combinations.
A, B Flux distributions were calculated for the extended Mtb metabolic network shown in Table EV1. Fluxes are absolute values expressed as mmol g-1 biomass h-1.
13C-labelled substrate consumption – acetate (ACE) and glycerol (GLYC) – and CO2 production fluxes were fixed for the calculations. Steady-state
13C mass
isotopomer measurements for the protein-derived amino acids from CHL-ACE and GLY-OLA grown Mtb were used for flux estimations. Estimated fluxes in File EV3
are represented by arrows in Fig 3A and B. The width of each line is proportional to the underlying flux value. Metabolite lists for the flux maps are included in
supplementary data file EV3.
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labelling data is complicated by the presence of significant
deuterium kinetic isotope effects (Liu et al, 2016). However, 2H trac-
ers have proved invaluable in resolving redox metabolism in
different organisms (Lewis Caroline et al, 2014; Jang et al, 2018).
Discussion
Mycobacterium tuberculosis is known to be able to acquire and





Figure 4. Flux distributions through the TCA cycle, glyoxylate shunt, anaplerotic pathways, glycolysis and gluconeogenesis for Mtb grown on CHL-ACE
and GLY-OLA.
A The network reactions for the TCA cycle (TCA R1, TCA R2, TCA R3, TCA R4, TCA R5, TCA R6, TCA R7), glyoxylate shunt (GLX R1, GLX R2) and anaplerotic reactions (ANA
R1, ANA R2) along with their directionalities are shown.
B Quantitative comparisons of the best-fit net fluxes derived from three chemostat cultivations and three technical replicates. The error bars on these measurements
show the lower and upper 95% confidence limits calculated using parameter continuation in INCA to determine the sensitivity of the minimised sum of squared
residuals as a function of the flux value. Two fluxes are considered significantly different if the confidence limits do not overlap (P < 0.05). Statistically significant
differences for the fluxes measured on the two growth substrates are indicated by *; ns denotes not significant.
C The network reactions for glycolysis (EMP R1, EMP R2, EMP R3, EMP R4, EMP R5, EMP R6) and for PPP (PPP R1, PPP R2, PPP R3, PPP R4) along with their
directionalities.
D The best-fit net fluxes for glycolysis and PPP, respectively, derived from three chemostat cultivations and three technical replicates. A negative flux indicated the
reverse directionality of the flux to that shown in A and C. The error bars on these measurements show the lower and upper 95% confidence limits for the fluxes
calculated using parameter continuation in INCA to determine the sensitivity of the minimised sum of squared residuals as a function of the flux value. Two fluxes
are considered significantly different if the confidence limits do not overlap (P < 0.05) Statistically significant differences for the fluxes measured on the two growth
substrates are indicated by *; ns denotes not significant.
E 13C incorporation in pyruvate (PYR) and PEP of Mtb grown in [3, 4-13C2] cholesterol. Values are shown as mean  s.e.m. of 3–4 biological replicates.
Data information: Metabolites shown in A and D are MALOAA (malate + oxaloacetate), SUC (succinate), ACCOA (acetyl coenzyme A), PYR (pyruvate), ICIT (isocitrate), GLX
(glyoxylate), OXG (a-ketoglutarate), SUCCOA (succinyl coenzyme A), FUM (fumarate), G6P (glucose-6-phosphate), F6P (fructose-6-phosphate), FBP (fructose 1,6-
bisphosphate), GAP (glyceraldehyde-3-phosphate), PGA (phosphoglyceric acid), PEP (phosphoenolpyruvate), PYR (pyruvate), P5P (pentose-5-phosphate), E4P (erythrose-
4-phosphate) and S7P (sedoheptulose-7-phosphate).
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including sugars, host-derived fatty acids, amino acids and choles-
terol as sources of nitrogen, carbon and energy during host infec-
tion. This co-catabolism has been demonstrated to occur both
in vitro and during intracellular growth (de Carvalho et al, 2010).
Details of the metabolic mechanisms involved in this process have
been inferred from 13C labelling experiments in which specific nutri-
ents were observed to have defined fates suggesting some form of




Figure 5. Flux distributions through the methyl citrate cycle and amino acid degradation pathways of Mtb grown on CHL-ACE and GLY-OLA.
A The network reactions for methyl citrate cycle (MCC R1, MCC R2, MCC R3) and amino acid degradation pathways (D R1, D R2, D R3, D R4, D R5, D R6, D R7) along
with their directionalities are shown.
B Best-fit absolute net fluxes of the methyl citrate cycle derived from three chemostat cultivations and three technical replicates. The error bars are lower and upper
95% confidence limits of the net fluxes calculated using parameter continuation in INCA to determine the sensitivity of the minimised sum of squared residuals as
a function of the flux value. Two fluxes are considered significantly different if the confidence limits do not overlap (P < 0.05).Statistically significant differences for
the fluxes measured on the two growth substrates are indicated by *; ns denotes not significant.
C, D Best-fit absolute net fluxes for valine degradation, threonine and isoleucine degradation on CHL-ACE and GLY-OLA derived from three chemostat cultivations and
three technical replicates. A negative flux indicated the reverse directionality of the flux to that shown in A. The error bars on these measurements show the lower
and upper 95% confidence limits for the fluxes calculated using parameter continuation in INCA to determine the sensitivity of the minimised sum of squared
residuals as a function of the flux value. Two fluxes are considered significantly different if the confidence limits do not overlap (P < 0.05). Fluxes are significantly
different if the confidence limits do not overlap. Statistically significant differences for the fluxes measured on the two growth substrates are indicated by *; ns
denotes not significant.
Data information: Abbreviations for metabolites are MALOAA (malate + oxaloacetate), SUC (succinate), ACCOA (acetyl coenzyme A), PYR (pyruvate), METCIT (methyl
citrate), METICIT (methyl isocitrate), MMCOA (methylmalonyl coenzyme A), ISOBUTCOA (isobutyl coenzyme A), OXBT (oxobutanoate), ILE (isoleucine), THR (threonine) and
MHCOA (methylacetoacetyl coenzyme A).
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However, in our steady-state, slow-growing cultures we demon-
strated efficient co-catabolism of either cholesterol and acetate, or
glycerol and oleic acid but found no evidence of compartmentalised
metabolism. This apparent discrepancy suggests that metabolic
compartmentalisation may be carbon source-dependent or may
reflect differences in experimental setup. The previous studies were
performed using Mtb grown in non-metabolic steady-state condi-
tions on Middlebrook 7H10 agar containing in addition to the
carbon sources (one of which was 13C labelled) significant amounts
of unlabelled glutamate which Mtb can use as both a nitrogen and a
carbon source (Lofthouse et al, 2013). The instationary metabolic
state of the culture would affect the rates of 13C incorporation into
intermediates, whilst the additional unlabelled carbon source would
have diluted out the label thus potentially confounding the analysis.
Compartmentalisation in prokaryotic cells can involve micro-
compartments or cages. These are semi-permeable protein shells
that sequester enzyme complexes from a segment of a metabolic
pathway, but that are permeable to metabolites. These structures
allow pathway reactions to be spatially organised and so can
enhance flux through multi-step pathways or protect cells from toxic
metabolic intermediates (Saier, 2013; Lau et al, 2018). To date, only
relatively small cages have been identified in mycobacteria, which
encapsulate pathways involved in oxidative stress and iron storage
pathways (Contreras et al, 2014). Mtb does not encode the various
subunits required to make-up the larger compartments that could,
for example, encage whole metabolic pathways. Therefore, with our
current knowledge, it is difficult to understand how Mtb could
segregate metabolites from single carbon sources through a large
pathway such as the TCA cycle, for example. The hypothesis that
Mtb compartmentalises central carbon metabolism thereby requires
further investigation.
The physiological role of Mtb’s glyoxylate shunt is to supply and
replenish the TCA and MCC cycle intermediates, oxaloacetate,
to ensure adequate supply for gluconeogenesis and amino acid
◀ Figure 6. Negative ion mode MALDI-ToF mass spectra showing the lipid fingerprint of Mtb under different carbon sources in chemostat.
A–D Ac1PIM2: tri-acyl phosphatidylinositol mannoside di-mannose; Ac2PIM2: tetra-acyl phosphatidylinositol mannoside di-mannose; Ac1PIM6: tri-acylated
phosphatidyl-myo-inositol hexamannoside; Ac2PIM6: tetra-acylated phosphatidyl-myo-inositol hexamannoside; and SL-I: sulpholipid. The ion at m/z 1413.9 is
assigned to the deprotonated PIM2 containing 2 C16:0 and 1 C19:0; the ion at m/z 1,694.1 is assigned to the deprotonated PIM2 containing 2 C16:0 and 2 C19:0;
the ion at m/z 2,062.1 is assigned to the deprotonated PIM6 containing 2 C16:0 and 1 C19:0; the ion at m/z 2,342.9 is assigned to the deprotonated PIM2 containing
2 C16:0 and 2 C19:0; and SL-I is observed as a broad set of peaks representing multiple lipoforms corresponding to differing numbers of CH2 units. Multiple
lipoforms of SL-1 (m/z 2500 to m/z 3000) are also indicated SL-I. Mass shifts due to 13C labelling of whole bacteria lipid fingerprint prepared from metabolic and
isotopic steady-state chemostat Mtb grown with [13C2] acetate and unlabelled cholesterol (A), [
13C3] glycerol and unlabelled Tween 80 (B), unlabelled acetate and
cholesterol (C) and unlabelled glycerol and Tween 80 (D). Samples taken from the same chemostat at metabolic steady state (A) and (B) and isotopic in stationary
state (C) and (D). The resolved mass shifts observed for Ac1PIM2 are shown to indicate significant lipid changes between the two conditions.
A B
Figure 7. Amino acid biosynthesis.
A Best-fit net fluxes derived from three chemostat cultivations and three technical replicates are shown for the synthesis of amino acids alanine (ala P), valine (val P),
leucine (leu P), tyrosine (tyr P), phenylalanine (phe P), histidine (his P), glutamine (gln P), glutamate (glu P), proline (pro P), ornithine (orn P), asparagine (asn P),
aspartate (asp P), threonine (thr P), isoleucine (ile P), methionine (met P), lysine (lys P), glycine (gly P), cysteine (cys P) and serine (ser P). The error bars on these
measurements show the lower and upper 95% confidence limits for the fluxes calculated using parameter continuation in INCA to determine the sensitivity of the
minimised sum of squared residuals as a function of the flux value. Two fluxes are considered significantly different if the confidence limits do not overlap (P < 0.05).
Statistically significant differences for the fluxes measured on the two growth substrates are indicated by *.
B 2H (deuterated hydrogen) incorporation in the amino acids of Mtb grown in minimal media with deuterated cholesterol as the sole carbon source. Values are
mean  s.e.m. (n = 3 biological replicates).
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synthesis by bypassing the decarboxylating steps of the TCA cycle
and thereby preserving carbon (Munoz-Elias & McKinney, 2005).
The pathway is now known to have a multifaceted role in microbial
growth and survival in a variety of conditions and is also critical for
the virulence of a number of pathogens including Mtb (Dolan &
Welch, 2018). During growth on CHL-ACE, Mtb had significantly
higher fluxes through both the complete TCA cycle and the glyoxy-
late shunt than when grown with GLY-OLA.
In the highly oxygenated chemostat, cholesterol catabolism will
generate reductants that need to be recycled (Mavi et al, 2019). Our
flux results demonstrate that during slow growth with CHL-ACE,
this is occurring via the TCA cycle and then through oxidation of
NADH in the electron transport chain. Our data also indicate that
lipids provide a sink for reductants in these conditions as has been
described previously (Lee et al, 2013). However, our studies using
deuterated cholesterol indicate that some reductant is also chan-
nelled into amino acid biosynthesis indicating that this provides
Mtb with another potential sink for reductants.
The relatively large amounts of CO2 produced from the CHL/ACE
culture are in concordance with a partitioning of isocitrate through a
complete TCA cycle and the glyoxylate shunt combined with gluco-
neogenic operation of PEPCK when growing on cholesterol and
acetate. This mode of operation is in stark contrast to Mtb growing
with GLY-OLA where we measured reduced flux through an incom-
plete TCA cycle and insignificant fluxes through the glyoxylate
shunt combined with anaplerotic flux through PEPCK that leads to
the lower CO2 release in Mtb grown on GLY-OLA. OAA supply is in
part satisfied by PEPCK functioning in the carboxylating direction,
confirming our previous result (Beste et al, 2011), whilst gluconeo-
genesis proceeds directly from glycerol-derived PGA. Although
MEZ, PCA (which are not distinguished in our model) and PEPCK
are all able to fix carbon from CO2 (Basu et al, 2018), PEPCK is
predicted by these results to be the dominant enzyme of the
anaplerotic node required for either gluconeogenesis or anaplerosis.
This explains why Mtb strains lacking PEPCK are attenuated in a
variety of different in vitro, ex vivo and in vivo conditions (Marrero
et al, 2010; Baker & Abramovitch, 2018; Basu et al, 2018).
Previous studies have shown that Mtb strains lacking the bifunc-
tional isocitrate lyase/methylisocitrate lyase (ICL) are unable to grow
in the presence of cholesterol because they cannot metabolise propi-
onate due to the role of this enzyme in the MCC (Lee et al, 2013).
However, the addition of C2 containing metabolites alleviates this
attenuation, by priming incorporation of propionyl-CoA into lipids
and so limiting the build-up of toxic MCC intermediates and propi-
onyl-CoA itself (Lee et al, 2013). Here, we show that even in the
presence of an intact MCC, the flux of carbon from cholesterol into
lipids is the preferred metabolic route when there are sufficient C2
metabolites to prime lipid biosynthesis as evidenced by the low flux
through the MCC in the slow growth chemostat conditions. This was
further confirmed by the lipid analysis which showed an increase in
the incorporation of carbon from cholesterol into SL-1 resulting in an
increase in chain length of this virulence lipid. Changes in SL-1 are
interesting as this lipid plays a critical role in inducing the character-
istic TB cough (Ruhl et al, 2020) thereby potentially linking clinical
manifestations with changes in carbon source availability.
The role of the glyoxylate shunt in Mtb pathogenesis has always
been obscured by the dual function of the gating enzyme ICL
enzyme in both the shunt and the MCC. Enzymes which function
exclusively in the MCC are known to be dispensable in murine
models of Mtb, prompting the hypothesis that vitamin B12-
dependent methylmalonyl pathway (MMP) complements for the
absence of the MCC pathway in vivo (Savvi et al, 2008). However,
this is not consistent with the finding that strains lacking both a
functional MCC and MMP but with a functioning glyoxylate shunt
were significantly less attenuated in a murine model of TB than Dicl
Mtb strains (Lotlikar, 2012). This indicates that in some conditions,
ICL’s only role is as the gateway enzyme into the glyoxylate shunt.
Here, we show that when Mtb is growing slowly with cholesterol
and fatty acids, there is very low flux through the MCC and the main
function of ICL is to channel carbon through the glyoxylate shunt.
We previously identified an additional essential role for ICL
during slow growth of Mtb on glycerol and Tween 80 using 13C MFA,
conditions in which the glyoxylate shunt would not be expected to be
active (Beste et al, 2011). Here, using our extended isotopologue
model, we demonstrate that under these conditions, ICL is catalysing
a reverse flux through the MCC in the direction leading to propionyl-
CoA generation. Reversal of the MCC has been described by Serafini
et al, (2019) when Mtb is growing with pyruvate or lactate (Serafini
et al, 2019). Our data suggest that this is a more general phenomena
and may be active whenever there is a limited supply of odd-chain
lipid precursors. The ability to operate the MCC as both a catabolic
and an anabolic pathway provides Mtb with the metabolic flexibility
to both detoxify excess sterol-derived propionate and, when neces-
sary, to generate propionyl-CoA for lipid biosynthesis, including viru-
lence-associated lipids. The generation of propionyl-CoA may be
particularly important when Mtb is growing slowly and in stress
conditions which are associated with increased demand for specific
cell wall lipids (Singh et al, 2009; Warner, 2014). This also suggests
that in conditions where a reversed MCC is required, the methyl-
malonyl pathway would be unable to complement the MCC pathway,
highlighting the necessity for both pathways.
A role for a reversed MCC in the co-metabolism of glycerol and
fatty acids is of interest in the context of the discovery that Mtb has
access to glycerol in vivo (Safi et al, 2019). Although unlikely to be
an essential carbon source, changes in glycerol metabolism have
been shown to influence antibiotic tolerance of Mtb in vivo
(Bellerose et al, 2019; Safi et al, 2019). Also, mutations in the MCC
regulator prpR that conferred multidrug tolerance were identified in
TB patients (Hicks et al, 2018). Although this finding was proposed
to reflect an impaired ability of these strains to metabolise propi-
onate, the results here suggest an alternative and intriguing hypothe-
sis that dysregulation of the MCC may affect the metabolism of
glycerol. Interestingly, Mtb strains lacking ICL were shown to be less
tolerant to antibiotics in glycerol containing medium and this was
associated with an increased flux through the TCA cycle (Nandakumar
et al, 2014). We posit that this is due to the operation of a reversed
MCC. When the MCC is reversed, methyl citrate lyase (ICL) becomes
the gating enzyme into this cycle, and therefore, as Nandakumar et al
eloquently demonstrated, DiclMtb strains would increase flux through
the TCA cycle, altering the energetics of the cell and reducing Mtb
tolerance to antibiotics (Nandakumar et al, 2014).
Surprisingly, our data predicted zero flux through the PPDK reac-
tion presumed to be catalysed by the product of Rv1127c and has
been shown by us, and others, to be essential for cholesterol and
propionate metabolism (Griffin et al, 2011; Basu et al, 2018).
PPDK’s use two binding domains, for ATP/AMP and PEP/pyruvate,
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to catalyse the reversible interconversion between pyruvate and
PEP. Mysteriously, analysis of Rv1127c reveals that although the
gene encodes an entire N-terminal PPDK domain to bind and
dephosporylate ATP, the predicted protein completely lacks a C-
terminal PEP/pyruvate-binding domain (Fig EV4), raising doubts
over the annotated function of this protein. Mycobacterium bovis,
Mycobacterium bovis BCG and Mycobacterium leprae encode similar
“PPDK” genes lacking PEP/pyruvate-binding domains. Although it
is possible that the mycobacterial PEP/pyruvate-binding domain is
encoded on another Mtb gene, in silico searches have not identified
any genes encoding Mtb proteins homologous to the C-terminal
PEP/pyruvate-binding domain of typical PPDK’s. Loci for function-
ally related genes tend to be in close genomic proximity in prokary-
otes and the Rv1127c locus is nearby genes encoding enzymes and
regulators of the methylcitrate cycle that, like Rv1127c, are essential
for the metabolism of cholesterol and propionate. The absence of
PEP/pyruvate-binding domain and, as we demonstrate in this study,
zero flux through the PPDK reaction in conditions in which Rv1127c
is essential prompts us to propose that Rv1127c is not a PPDK but
performs an, as yet unknown, metabolic function associated with
the methylcitrate cycle. This would be consistent with our previous
data demonstrating propionate vulnerability of strains lacking
Rv1127c that could be complemented by vitamin B12 to activate the
methylmalonyl pathway. The precise function of Rv1127c may have
therapeutic implications as DRv1127c is attenuated for intracellular
survival and is more sensitive to the antibiotic bedaquiline (Macken-
zie et al, 2020). Rv1127c is thereby an attractive target for develop-
ing anti-TB drugs which synergise with bedaquiline, a critical drug
in the new shortened therapy against drug-resistant TB.
In conclusion, our results demonstrate that Mtb efficiently co-
metabolises combinations of either glycerol or cholesterol along
with C2 generating substrates to efficiently generate biomass.
Although it has been suggested that Mtb is able to differentially co-
metabolise carbon substrates to distinct metabolic fates, we find no
evidence of compartmentalised metabolism in this study suggesting
that this hypothesis may need re-evaluating. We show that a rever-
sible MCC pathway along with the glyoxylate shunt provides Mtb
with a high level of flexibility for re-routing metabolic fluxes
depending on the combination of carbon sources being metabolised
to generate biomass and in particular mycolipids. For example, we
show that Mtb re-routes carbon flux through a reversed MCC when
growing on glycerol and Tween 80. Finally, we find no evidence for
PPDK flux under the conditions where it would be expected, indicat-
ing that Rv1127c is incorrectly annotated and that its actual role in
the MCC remains unknown. Overall, this work illustrates the
flexibility of Mtb metabolism, and how it is able to adapt to the dif-
ferent combinations of nutrients that this pathogen might encounter
during infection. The work also highlights the importance of explor-
ing metabolic flux profiles in different conditions if we wish to fully
comprehend metabolic potential of Mtb.
Materials and Methods
Bacterial strains and growth conditions
Mycobacterium tuberculosis (H37Rv) was grown in a 2 litre bioreac-
tor (Adaptive Biosystem Voyager) under aerobic conditions and at
pH 6.6 as previously described (Beste et al, 2011). Chemostat
cultures were grown in Roisin’s minimal medium at a constant dilu-
tion rate of 0.01 h1 (slow growth rate). Culture samples were with-
drawn from the chemostat to monitor cellular dry weight, viable
counts, optical density and nutrient utilisation, and CO2 and O2
levels were measured in the exhaust gas (Beste et al, 2011). Meta-
bolic steady state was confirmed from the OD600, substrate
consumption and CO2 production rates.
Once metabolic steady state was reached, 13C labelling experi-
ments were initiated in the chemostat by replacing the feed medium
with an identical medium containing a mixture of unlabelled and
labelled carbon sources. Two mixtures of (i) 100% U-[13C2] acetate
and unlabelled cholesterol, or (ii) 30% U-[13C3] glycerol and unla-
belled Tween 80 were used as carbon substrates in Roisin’s minimal
media. To confirm isotopic steady state, cultures were withdrawn at
regular intervals and the amount of 13C label incorporation was
measured using gas chromatography–mass spectrometry (GC-MS)
analysis for every volume change.
To explore the potential flux through PPDK, Mtb was grown in
Roisin’s minimal medium containing 0.1% (vol/vol) [3, 4-13C2]
cholesterol as the sole carbon source until mid-log phase
(OD600 = 0.6–0.8) before being harvested to analyse isotopologue
incorporation into intracellular metabolites. To evaluate the incor-
poration of 2H into the amino acids of Mtb, deuterated cholesterol
(0.0625 g/l) was used as the single carbon source in Roisin’s media.
Deuterated cholesterol was prepared using a recombinant Pichia
pastoris strain CBS7435 Dhis4Dku70 Derg5::pPpGAP-ZeocinTM-
[DHCR7] Derg6::pGAP-G418[DHCR24] (54). Cultures were adapted
to growth in deuterated minimal in the Deuteration Laboratory (D-
Lab) within the Life Sciences of the Institut Laue-Langevin
(Haertlein et al, 2016) and purified as described (Moulin et al,
2018). Mtb cultures grown in deuterated cholesterol were harvested
at the mid-log phase for metabolomics.
Culture analysis and substrate uptake measurements
Biomass and supernatant samples were collected and harvested
(Beste et al, 2011). The amounts of glycerol in the supernatant and
in fresh medium were assayed by use of a commercial assay kit that
employs a glycerokinase-coupled enzyme assay system (Boehringer
Mannheim). To assay for Tween 80, supernatant samples were
hydrolysed by boiling for 1 h in methanolic KOH (5% potassium
hydroxide: 50% methanol). After neutralising the samples with HCl,
the free fatty acids were assayed using a commercial kit (Roche).
Concentrations of cholesterol and acetate were measured using
commercial kits supplied by Boehringer Mannheim.
Biomass hydrolysate preparation and gas chromatography–mass
spectrometry (GC-MS) analysis
Biomass samples from the 13C-labelled chemostat and mid-log batch
cultures were washed and hydrolysed in 6 M Hydrochloric acid for
24 h (6). The dried hydrolysate was dissolved in 1 ml norvaline
solution (0.075 mM in 80∶20 H2O:MeOH). 0.1 ml was dried in-
vacuo and this mixture was derivatised by adding 140 µl acetonitrile
and N-tert-butyldimethylsilyl-N-methyltrifluoroacetamide (MTBSTFA),
1% tert-butyldimethylchlorosilane (TBDMCSI) (1:1) sonicating
(room temperature, 30 min) and then heating (90°C, 30 min) to
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complete the derivatisation. Samples were analysed by GC-MS
within 72 h after derivatisation.
The analysis was performed with a GC system (Agilent) fitted
with a DB-5ms capillary column (15 m × 0.18 mm internal diame-
ter × 0.18 µm film with 5 m Duraguard integrated guard column)
and deactivated quartz wool packed FocusLiner (SGE) coupled to a
Pegasus III time-of-flight (TOF) mass spectrometer (Leco) equipped
with a splitless injector. The injector temperature was initially held
at 70°C for 2 min followed by heating to 350°C at a rate of 17°C/
min. This temperature was held for 1.5 min. The He Carrier flow
was held constant at 1.4 ml/min. The injection volume was 5 µl,
and inlet temperature was 250 °C, interface temperature at 310 °C
and source temperature at 245°C. The system was operated with a
mass range of 40–800 m/z at an EM voltage of 70 eV with a spectral
acquisition rate of 20 spectra/s. 13C isotopologue abundances (i.e.
13C incorporation; U-12C, 13C1, . . .,
13Cn) for each amino acid were
determined for fragments containing the intact carbon skeleton for
each amino acid, generally using the [M-57]+ ion. To obtain further
information relating to the 13C incorporation at individual positions
within individual amino acids, isotopologue abundances were also
determined for fragments formed by cleavage of the C1–C2 bond in
some samples. Within a subset of these, isotopologue abundances
for the fragment formed by cleavage of the C2–C3 bond in serine
were also determined allowing comprehensive characterisation of
the isotopic incorporation into serine. Mass spectra of the deriva-
tised amino acids were corrected for the natural abundance of all
stable isotopes (Beste et al, 2011; Borah et al, 2019).
Sample preparation and liquid chromatography–mass
spectrometry (LC-MS) analysis
For the detection of intracellular metabolites, cultures were
quenched in a solution of 60% methanol and 0.9% NaCl at 20°C.
The metabolites were extracted in a pre-chilled (20°C) solution of
methanol:chloroform (1:1), and cells were lysed twice by bead beat-
ing in the FastPrep at 6.5 for 20 s with careful cooling in between.
Soluble extracts were filtered twice and then stored at 80°C until
analysis by LC-MS.
Samples for 13C isotopomer profiling of organic acids and sugar
phosphates were separated using a synergy hydro C18 reversed
phase column on an Agilent 1200 chromatography system (Agilent
Technologies, Waldbronn, Germany). Free amino acids were sepa-
rated using a Luna SCX cation exchange column on a JASCO HPLC
system. In both cases, the HPLC outlets were coupled to an API
4000 (Applied Biosystems, Concord, Canada) mass spectrometer
equipped with a TurboIon spray source. The separation methods,
optimal MS parameter settings as well as extraction and integration
of ion chromatograms as described (Kappelmann et al, 2017).
MALDI lipid fingerprinting
A late log phase culture was washed in phosphate buffer saline by
centrifugations and heat killed. The heat-inactivated was further
washed three times in water and resuspended in 100 µl. An aliquot
of 0.4 ll of the mycobacterial solution was loaded onto the target
and immediately overlaid with 0.8 ll of 10 mg/ml super-2,5-dihy-
droxybenzoic acid (sDHB) matrix in chloroform/methanol (CHCl3/
MeOH) 90:10 v/v. The mycobacterial sample and matrix were
mixed directly on the target by pipetting and allowed to dry under a
stream of air. MALDI-TOF MS analysis was performed on a 4800
Proteomics Analyzer (Applied Biosystems) using the reflectron
mode. Samples were analysed by operating at 20 kV in the negative
ion mode using an extraction delay time set at 20 ns.
Metabolic modelling
Metabolic modelling was conducted using INCA, version 1.7 (Young,
2014). An extended isotopomer model of central metabolism
(Table EV1) in Mtb was constructed of the model previously
published (Beste et al, 2011). In addition to the reactions of glycoly-
sis (EMP), gluconeogenesis, the pentose phosphate pathway (PPP),
the tricarboxylic acid cycle (TCA) and anaplerosis (ANA), we
included the reactions of the MCC and amino acid degradation path-
ways. This metabolic network model was supplemented with carbon
atom transitions and consisted of a total of 90 reactions and 51
exchange reactions. Labelling measurements were obtained using
100% [U-13C2] acetate for CHL-ACE and 30% [U-
13C3] glycerol for
GLY-OLA. Flux values for net and exchange rates were derived from
86 independent flux parameters that are estimated using 108 label-
ling measurements for CHL-ACE and 120 for GLY-OLA, respectively
(supplementary data file S1). Substrate consumption rates for choles-
terol, acetate, glycerol and Tween 80 and overall CO2 net production
rate (Table 1) were used as fixed fluxes to constrain the model.
Metabolic flux estimation
Flux estimations were performed using INCA (Young, 2014) using
non-linear weighted least squares fitting approach to determine the
flux values which are the most likely description of the labelling
data and biomass constraints (Beste et al, 2011). INCA performs a
Levenberg–Marquardt gradient-based search algorithm to minimise
the sum of squared residuals (SSR) between the simulated and
experimental measurements (Wiechert, 2001; Young, 2014). A
multistart optimisation approach was used for flux estimations with
a total number of restarts of 100. Flux distributions with a minimum
statistically acceptable SSR were considered the best fit. The good-
ness of fit of the flux maps was assessed by comparing the simu-
lated and experimental measurements. The upper and lower 95%
confidence limits of the best-fit flux distributions were calculated
using parameter optimisation option in INCA (Young, 2014). Fluxes
were considered to be significantly different if the 95% confidence
limits do not overlap.
Data availability
The raw and processedmass isotopomer data and estimated fluxes are
included as Tables EV2 and EV3. The isotopomer model is deposited
onGitHub (https://github.com/KB-2021/TB-metabolic-model.git).
Expanded View for this article is available online.
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